Search results

  1. ME/CFS Science Blog

    News from Scandinavia

    'a gradual increase in activity helps people recover.' 'This new research provides evidence for treatments that will help people recover, and is consistent with the approach the Oslo Networks understanding of these conditions.' Signed by Paul Garner who was one of the authors of the BMJ review.
  2. ME/CFS Science Blog

    2024: Call for a Research Case Definition Consensus Statement for ME/CFS

    I interpreted the statement as highlighting current problems with ME/CFS case definitions, so more a starting point for discussion than a specific proposal on how things should be. I think the required impairment for ME/CFS diagnosis, definition of PEM, and exclusionary conditions are good...
  3. ME/CFS Science Blog

    Meta-analysis of Natural Killer (NK) cell cytotoxicity in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), 2024, Baraniuk et al

    The MCAM did test their methods first to check if it correlated with the gold standard of chromium-51 release tested on whole blood on the same day. https://pubmed.ncbi.nlm.nih.gov/33819446/
  4. ME/CFS Science Blog

    Meta-analysis of Natural Killer (NK) cell cytotoxicity in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), 2024, Baraniuk et al

    It also seems that the authors have included multiple estimates from the same study (for example different E:T ratios). I don't think their modelling accounts from the correlation between these, so it is similar to counting some studies multiple times.
  5. ME/CFS Science Blog

    Meta-analysis of Natural Killer (NK) cell cytotoxicity in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), 2024, Baraniuk et al

    12 out of the 28 studies in the review came from the same research team as the reviewers at Griffith University. There are also 4 from the Klimas group in Florida who previously advocated this line of research. Other studies are rather old, from before 2000.
  6. ME/CFS Science Blog

    Review ‘Pacing’ for management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review and meta-analysis, 2024, Sanal-Hayes

    I don't think these estimates are useful. The authors have thrown 2 case studies with less than 10 participants and no control group in the mix. This entirely messes up the meta-analysis. The only 2 randomized studies are the PACE trial and this small Belgian study...
  7. ME/CFS Science Blog

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    We have written a blog article that summarizes the problems with the BMJ review on Long Covid interventions (Zeraatkar et al. 2024). Inconsistency in how imprecision was evaluated seems to be the key issue. Suspect that a correction will be needed...
  8. ME/CFS Science Blog

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    Been looking closer into this. One interpretation might be that including all randomized participants is assuming that those with missing data did not had the outcome (in our example improvement/recovery), so a form of imputation (non-responder imputation). Cochrane seems to recommend not...
  9. ME/CFS Science Blog

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    Intention to treat In the protocol the authors said they were going to use intention-to-treat (ITT): "reviewers will preferentially extract the results from intention-to-treat analyses without any imputations for missing data, when reported." But if you look at the data they extract in the Excel...
  10. ME/CFS Science Blog

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    A minus sign I think. the - before the 13.11 got accidentally deleted when I made the table. The estimate is −8.4, 95% confidence interval (CI) −13.11 to −3.69. So it is above the MID of 3 points and does not cross 0. I assume this is what you referred to? Apologies for the confusion (will...
  11. ME/CFS Science Blog

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    Here's why I'm asking about precision: the outcomes above that were downgraded twice were non-behavioral interventions with low risk of bias. Those what were not downgraded were rehabilitative interventions and all high risk of bias. So because of this weird approach to evaluating precision...
  12. ME/CFS Science Blog

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    Imprecision I think there is an issue with how they evaluated (im)precision and was hoping if anyone could double-check. In short, precision is determined by the variation in the measurement (e.g. standard deviation) and the amount of information collected (sample size). In the protocol the...
  13. ME/CFS Science Blog

    Bias due to a lack of blinding: a discussion

    Meta-epidemiological evidence that randomization and allocation concealment overestimate treatment effects is also weak. Take for example this latest overview where Guyatt was senior author and where the overestimation because of lack of blinding was actually bigger than for randomization and...
  14. ME/CFS Science Blog

    Bias due to a lack of blinding: a discussion

    GRADE is getting a big update and some parts are already available in this new book: https://book.gradepro.org/ Unfortunately, it includes the following passage: The meta-epidemiological evidence refers to the MetaBLIND study. This might explain why reviewers (such as those that wrote the...
  15. ME/CFS Science Blog

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    This is a living review which will be regularly updated (every 6 months or sooner if there is important new evidence) and the authors have funding to this for at leats 3 years. Perhaps the patients involved could highlight some of these problems?
  16. ME/CFS Science Blog

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    Except for two cognitive tests, all of their outcomes are subjective. I think this might become a problem if more rehabilitation trials are done where subjective outcomes show an improvement but objective outcomes (6minute walking test, CPET, employment etc) don't. It might cause the same issues...
  17. ME/CFS Science Blog

    Understanding Statistics

    Tilestats is also useful because he often breaks it down to the by hand calculation: https://www.youtube.com/@tilestats A similar YouTube account is Statquest by Josh Starmer: https://www.youtube.com/@statquest/videos
  18. ME/CFS Science Blog

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    Yes according to their standards, this should have at least the same certainty of evidence. But they downgraded it twice, once for selective reporting and the second time because the reviewers believed there is no plausible mechanism:
Back
Top Bottom